Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes WE.

Clin Infect Dis. 1999 Feb;28(2):291-6.

PMID:
10064246
2.

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE.

Clin Infect Dis. 2000 Apr;30(4):710-8. Epub 2000 Apr 20.

PMID:
10770733
3.

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE.

N Engl J Med. 1997 Jul 3;337(1):15-21.

4.
5.

The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.

Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Choksawadphinyo K.

J Med Assoc Thai. 2003 Apr;86(4):293-8.

PMID:
12757072
6.

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, et al.

N Engl J Med. 1992 Jan 9;326(2):83-9.

7.

The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.

Nelson MR, Fisher M, Cartledge J, Rogers T, Gazzard BG.

AIDS. 1994 May;8(5):651-4. Review.

PMID:
8060545
8.

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, de Marie S.

AIDS. 1997 Oct;11(12):1463-71.

PMID:
9342068
9.

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.

Friese G, Discher T, Füssle R, Schmalreck A, Lohmeyer J.

AIDS. 2001 Nov 23;15(17):2344-5. No abstract available.

PMID:
11698718
10.

Recent advances in the management of cryptococcal meningitis in patients with AIDS.

Powderly WG.

Clin Infect Dis. 1996 May;22 Suppl 2:S119-23. Review.

PMID:
8722838
12.

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

Bozzette SA, Larsen RA, Chiu J, Leal MA, Jacobsen J, Rothman P, Robinson P, Gilbert G, McCutchan JA, Tilles J, et al.

N Engl J Med. 1991 Feb 28;324(9):580-4.

13.

[Therapy of candidiasis and cryptococcosis in AIDS].

Just-Nübling G.

Mycoses. 1994;37 Suppl 2:56-63. Review. German.

PMID:
7609745
14.

Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.

Mayanja-Kizza H, Oishi K, Mitarai S, Yamashita H, Nalongo K, Watanabe K, Izumi T, Ococi-Jungala, Augustine K, Mugerwa R, Nagatake T, Matsumoto K.

Clin Infect Dis. 1998 Jun;26(6):1362-6.

PMID:
9636863
15.

Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.

de Gans J, Portegies P, Tiessens G, Eeftinck Schattenkerk JK, van Boxtel CJ, van Ketel RJ, Stam J.

AIDS. 1992 Feb;6(2):185-90.

PMID:
1313682
16.

Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period.

de Lalla F, Pellizzer G, Vaglia A, Manfrin V, Franzetti M, Fabris P, Stecca C.

Clin Infect Dis. 1995 Feb;20(2):263-6.

PMID:
7742427
17.

Efficacy of fluconazole in cryptococcal meningitis.

Jones PD, Marriott D, Speed BR.

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):235S-238S.

PMID:
2556240
18.

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.

Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, Dellamonica P, Botterel F, Dromer F, Chêne G.

AIDS. 2006 Nov 14;20(17):2183-91.

PMID:
17086058
19.

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

Wheat J, MaWhinney S, Hafner R, McKinsey D, Chen D, Korzun A, Shakan KJ, Johnson P, Hamill R, Bamberger D, Pappas P, Stansell J, Koletar S, Squires K, Larsen RA, Cheung T, Hyslop N, Lai KK, Schneider D, Kauffman C, Saag M, Dismukes W, Powderly W.

Am J Med. 1997 Sep;103(3):223-32.

PMID:
9316555
20.

Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.

Witt MD, Lewis RJ, Larsen RA, Milefchik EN, Leal MA, Haubrich RH, Richie JA, Edwards JE Jr, Ghannoum MA.

Clin Infect Dis. 1996 Feb;22(2):322-8.

PMID:
8838190

Supplemental Content

Support Center